News items related to:
-
• The US FDA announces that its panel of external vaccine advisors will meet on 17 September to discuss the...
-
1 September 2021
• Merck and development partner Ridgeback Pharmaceuticals issue a press release to announce a phase III trial of molnupiravir, a...
-
31 August 2021
• China’s Livzon Pharmaceutical Group announced that the Philippines FDA approved the phase III trial of V-01, its experimental protein-based coronavirus...
-
30 August 2021
• Researchers in South Africa report concerns about a new coronavirus variant, C.1.2, which was first identified in May 2021...
-
29 August 2021
• In Japan, where 44 percent of the population is fully vaccinated, government officials are considering whether to mix first...
-
28 August 2021
• In Japan, two men died after receiving a second dose of Moderna’s coronavirus vaccine from a batch that had...
-
27 August 2021
• The British Medical Journal publishes a paper on the risk of blood clots with low platelets among adults in...
-
26 August 2021
• The Economist Intelligence Unit releases a report, How much will vaccine inequity cost, summarizes the current state of access...
-
25 August 2021
• Officials in at least 12 Chinese cities warn unvaccinated residents that they will be held accountable if they are...
-
24 August 2021
• Coronavirus cases in the US surpass 38 million. Source • US President Biden receives a report on the origins...
-
23 August 2021
• The US FDA grants full approval for the Pfizer/BioNTech coronavirus vaccine for people ages 16 and over (it will...
-
22 August 2021
• Dr. Zhong Nanshan, China’s leading expert in respiratory diseases, says that he hopes China could reach herd immunity by...